Opinion
ID Blog: The story of syphilis, part II
- Author:
- Mark S. Lesney
The transformation of syphilis from a highly lethal epidemic to a slow-burning, chronic disease provides a...
News
New engineered HIV-1 vaccine candidate shows improved immunogenicity in early trial
- Author:
- Mark S. Lesney
ALVAC-HIV vaccine showed immunogenicity across several HIV clades in an early trial involving 100 healthy...
News
Hospital-acquired C. diff. tied to four ‘high-risk’ antibiotic classes
- Author:
- Mark S. Lesney
High-risk antibiotics included second-, third-, and fourth-generation cephalosporins, fluoroquinolones, carbapenems, and lincosamides.
News
New genotype of S. pyrogenes found in rise of scarlet fever in U.K.
- Author:
- Mark S. Lesney
The new genotype of Streptococcus pyrogenes with increased scarlet fever toxin A production became...
Article
Can we eradicate malaria by 2050?
- Author:
- Mark S. Lesney
A Lancet Commission report details a series of modeled projections that could point the way.
News
Post-Ebola mortality five times higher than general population
- Author:
- Mark S. Lesney
Age, area of residence (urban vs. nonurban area), and duration of stay in an Ebola treatment center were independently and significantly...
Opinion
ID Blog: The story of syphilis, part I
- Author:
- Mark S. Lesney
Syphilis is on the rise again. Our blogger looks back on how it got here in the first place.
News
HCV coinfection adds to cardiovascular risk in HIV-infected patients
- Author:
- Mark S. Lesney
HCV and an accumulation of other viral/bacterial coinfections were associated with the risk of developing a CV...
News
FDA approves drug combo to treat highly resistant TB
- Author:
- Mark S. Lesney
The combination of pretomanid tablets with bedaquiline and linezolid primarily was approved for a limited...
News
Possible role of enterovirus infection in acute flaccid myelitis cases detected
- Author:
- Mark S. Lesney
High levels of enterovirus peptides were found in the cerebral spinal fluid of individuals with AFM.
News
Favorable Ebola results lead to drug trial termination, new focus
- Author:
- Mark S. Lesney
Two of four therapeutics showed greater Ebola survival, prompting termination of the initial trial and...
News
AHA highlights limitations of perfusion testing for critical limb ischemia
- Author:
- Mark S. Lesney
Perfusion assessment techniques for CLI remain limited and major differences in assessment, comorbidities, and...
News
HCV-infected people who inject drugs also have substantial alcohol use
- Author:
- Mark S. Lesney
Moderate (21%) and heavy (38%) alcohol use was common in HCV-infected people who injected drugs.
News
DRC Ebola epidemic continues unabated despite international response
- Author:
- Mark S. Lesney
HHS summarized the U.S. response to Ebola on the 1-year anniversary of the latest outbreak, which continues unabated in the Democratic Republic of...
News
Spleen/liver stiffness ratio differentiates HCV, ALD
- Author:
- Mark S. Lesney
The SS/LS ratio is significantly higher in patients with HCV than in those with alcohol-related liver disease (ALD).